Abstract
The aim of the present article was to review the role of the placenta function in the transfer of immunosuppressants and monoclonal antibodies used for the treatment of inflammatory bowel disease, as well as the available data regarding the safety of these therapies during pregnancy. Methotrexate can cause congenital abnormalities and is contraindicated during pregnancy. Available data suggest that thiopurines are safe and well tolerated during pregnancy. Treatment with cyclosporine for steroid refratory ulcerative colitis during pregnancy can be considered effective and safe. Biological therapies appear to be safe during pregnancy, as no increased risk of malformations has been demonstrated. Transplacental exchanges are known to involve passive transfer, active transport and facilitated diffusion. Thiopurines are transported by passive transfer. The transport across the placenta of corticosteroids, methotrexate and cyclosporine is modulated by protein “pumps”. Infliximab and adalimumab bind the FcRn-receptor as other IgG proteins do. The mechanisms of the diffusion of certolizumab across the placenta barrier remain unknown.
Keywords: Adalimumab, azathioprine, inflammatory bowel disease, infliximab, mercaptopurine, methotrexate, pregnancy, potential toxicity to the fetus, teratogenicity, Crohn's disease, ulcerative colitis, fertility, transfer of immunosuppressants
Current Pharmaceutical Biotechnology
Title: Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
Volume: 12 Issue: 5
Author(s): Maria Chaparro and Javier P. Gisbert
Affiliation:
Keywords: Adalimumab, azathioprine, inflammatory bowel disease, infliximab, mercaptopurine, methotrexate, pregnancy, potential toxicity to the fetus, teratogenicity, Crohn's disease, ulcerative colitis, fertility, transfer of immunosuppressants
Abstract: The aim of the present article was to review the role of the placenta function in the transfer of immunosuppressants and monoclonal antibodies used for the treatment of inflammatory bowel disease, as well as the available data regarding the safety of these therapies during pregnancy. Methotrexate can cause congenital abnormalities and is contraindicated during pregnancy. Available data suggest that thiopurines are safe and well tolerated during pregnancy. Treatment with cyclosporine for steroid refratory ulcerative colitis during pregnancy can be considered effective and safe. Biological therapies appear to be safe during pregnancy, as no increased risk of malformations has been demonstrated. Transplacental exchanges are known to involve passive transfer, active transport and facilitated diffusion. Thiopurines are transported by passive transfer. The transport across the placenta of corticosteroids, methotrexate and cyclosporine is modulated by protein “pumps”. Infliximab and adalimumab bind the FcRn-receptor as other IgG proteins do. The mechanisms of the diffusion of certolizumab across the placenta barrier remain unknown.
Export Options
About this article
Cite this article as:
Chaparro Maria and P. Gisbert Javier, Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease, Current Pharmaceutical Biotechnology 2011; 12 (5) . https://dx.doi.org/10.2174/138920111795470903
DOI https://dx.doi.org/10.2174/138920111795470903 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Peripheral Benzodiazepine Receptor Ligands and their Anti-Inflammatory Effects
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents New Insight into P-Glycoprotein as a Drug Target
Anti-Cancer Agents in Medicinal Chemistry CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimers Disease
Current Alzheimer Research Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
Current Drug Metabolism Pharmacology and Therapeutic Applications of Enediyne Antitumor Antibiotics
Current Molecular Pharmacology Synthesis and Anticancer Activity Evaluation of Some Benzothiazole-Piperazine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Tipping the Balance Between Life and Death: Targeting Histone Acetylation for Cancer Therapy
Drug Delivery Letters Aging and Inflammation: Etiological Culprits of Cancer
Current Aging Science Busulphan in Blood and Marrow Transplantation: Dose, Route, Frequency and Role of Therapeutic Drug Monitoring
Current Clinical Pharmacology Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Hybrid Molecules Development: A Versatile Landscape for the Control of Antifungal Drug Resistance: A Review
Mini-Reviews in Medicinal Chemistry DNA and RNA Code-reading Molecules as Potential Gene Silencers in Neurobiology- What are They and what are They Good for?
Current Medicinal Chemistry - Central Nervous System Agents Malignancy in Common Variable Immune Deficiency: Report of Two Rare Cases of Gastrointestinal Malignancy and a Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
Current Cancer Drug Targets FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract
Current Drug Targets Bypass Mechanisms of Resistance to Tyrosine Kinase Inhibition in Chronic Myelogenous Leukaemia
Current Drug Discovery Technologies Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Bladder Cancer and Stem Cells
Current Signal Transduction Therapy Gastrin: An Acid-Releasing, Proliferative and Immunomodulatory Peptide?
Mini-Reviews in Medicinal Chemistry